Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

VERO
Venus Concept Inc. Common Stock
stock NASDAQ

At Close
Jun 11, 2025 3:59:30 PM EDT
2.54USD+0.794%(+0.02)193,120
2.49Bid   2.53Ask   0.04Spread
Pre-market
Jun 11, 2025 9:20:30 AM EDT
2.43USD-3.571%(-0.09)13,131
After-hours
Jun 11, 2025 4:48:30 PM EDT
2.55USD+0.394%(+0.01)16,961
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 18, 2022
04:05PM EST  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Venus BlissMAX device (BlissMAX) in the United States.   GlobeNewswire Inc
11:11AM EST  Venus Concept Granted FDA 510K Clearance For Venus BlissMAX   Benzinga
Jan 14, 2022
09:13AM EST  Venus Concept Files Prospectus Relates To Resale, From Time To Time, By Selling Stockholders Of Up To 13.6M Shares Of Common Stock   Benzinga
Jan 10, 2022
07:47AM EST  Venus Concept Sees Q4 Sales $32M-$33M Vs. $31.82M Est., FY21 Sales $105M-$106M Vs. $104.81M Est.   Benzinga
07:00AM EST  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2021.   GlobeNewswire Inc
Jan 4, 2022
01:13PM EST  Venus Concept Tweets '...More than 40,600,000+ hair follicles have been harvested in 2021. With a forecasted 15% CAGR (compound annual growth rate), there is no better time to capitalize on the growing hair restoration market.'   Benzinga
Dec 15, 2021
09:07AM EST  Venus Concept Announces $17M Equity Financing Led By Masters Special Situations   Benzinga
09:00AM EST  Venus Concept Announces $17 Million Equity Financing led by   GlobeNewswire Inc
Dec 2, 2021
06:26AM EST  Venus Concept CEO Domenic Serafino Reported Purchase of 37,500 @ Avg Price of $1.32/Share in Form 4 Filing on Wednesday   Benzinga
Nov 12, 2021
11:23AM EST  How Bad Are Venus Concept's Earnings? | Return On Capital Employed   Benzinga
07:00AM EST  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2021.   GlobeNewswire Inc
04:26AM EST  Earnings Scheduled For November 12, 2021   Benzinga
Nov 11, 2021
10:59AM EST  Earnings Outlook For Venus Concept   Benzinga
Oct 28, 2021
09:33AM EDT  Venus Concept Sponsored Study Titled 'Clinical Evaluation of the Efficacy of Fractional Radiofrequency for the Treatment and Reduction of Stretch Marks' Posted To ClinicalTrials.gov; Recruitment Completed   Benzinga
Oct 25, 2021
11:28AM EDT  Venus Concept Study Titled 'Robotic Mechanical Coring for the Treatment of Moderate to Severe Facial Wrinkles' Posted To ClinicalTrials.Gov; Study Not Yet Recruiting   Benzinga
Oct 19, 2021
03:39PM EDT  Venus Concept's Pain Management Device Scores FDA Nod   Benzinga
07:31AM EDT  Venus Concept Receives FDA 510(k) Clearance For The Venus Freedom   Benzinga
07:30AM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Venus Freedom device in the United States.   GlobeNewswire Inc
06:03AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 05.50 A.M. EDT).   RTTNews
Oct 15, 2021
08:35AM EDT  Venus Concept S-3 Shows Registration For ~$55M Mixed Securities Shelf Offering   Benzinga
Oct 12, 2021
07:30AM EDT  Venus Concept Appoints Ross J. Portaro as President of Global Sales   GlobeNewswire Inc
Oct 4, 2021
04:05PM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal year 2021 financial results will be released before the market opens on Friday, November 12, 2021.   GlobeNewswire Inc
Oct 1, 2021
11:15AM EDT  How Good Are Venus Concept's Earnings? | Return On Capital Employed   Benzinga
Sep 7, 2021
04:05PM EDT  Venus Concept Inc. to Present at the H.C. Wainwright 23rd Annual   GlobeNewswire Inc
Aug 13, 2021
07:37AM EDT  Recap: Venus Concept Q2 Earnings   Benzinga
07:09AM EDT  Venus Concept Sees FY21 Sales $102M-$107M vs $103.24M Est.   Benzinga
07:08AM EDT  Venus Concept Q2 EPS $0.01 Beats $(0.12) Estimate, Sales $25.80M Beat $24.26M Estimate   Benzinga
07:05AM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2021.   GlobeNewswire Inc
04:12AM EDT  Earnings Scheduled For August 13, 2021   Benzinga
Aug 12, 2021
04:05PM EDT  Venus Concept Inc.(Venus Concept or the Company)(NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Sidoti & Co. Microcap Conference, which will be held virtually from August 18th-19th.   GlobeNewswire Inc
Jul 20, 2021
07:08AM EDT  Venus Concept Announces Health Canada Authorization And CE Mark For Venus Fiore Feminine Health System   Benzinga
07:00AM EDT  Venus Concept Announces Health Canada Authorization and CE Mark   GlobeNewswire Inc
Jul 12, 2021
10:45AM EDT  Venus Concept Inc.(Venus Concept or the Company)(NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Ladenburg Thalmann Healthcare Conference.   GlobeNewswire Inc
Jul 8, 2021
04:05PM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that second quarter of fiscal year 2021 financial results will be released before the market opens on Friday, August 13, 2021.   GlobeNewswire Inc
Jun 16, 2021
05:30AM EDT  Venus Concept CEO Dominec Serafino Reported Purchase of 40,000 Shares @ Avg Price of $2.46/Share in Form 4 Filing on Tuesday   Benzinga
May 17, 2021
04:42PM EDT  Venus Concept: Q1 Earnings Insights   Benzinga
04:10PM EDT  Venus Concept Raises FY21 Sales Guidance From $98M-$103M To $100M-$105M vs $100.66M Est.   Benzinga
04:09PM EDT  Venus Concept Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $22.60M Beat $21.30M Estimate   Benzinga
04:05PM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2021.   GlobeNewswire Inc
04:10AM EDT  Earnings Scheduled For May 17, 2021   Benzinga
Apr 21, 2021
01:34PM EDT  Venus Concept Shares Move Higher; Co Tweets 'Did you know that the demand for #SkinResurfacing treatments had grown 5% in the past 5 years? On Tuesday, May 4, join renowned dermatologist Dr. Heidi Waldorf for a webinar to learn about her experience...'   Benzinga
Apr 8, 2021
07:30AM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that first quarter of fiscal year 2021 financial results will be released after the market closes on Monday, May 17, 2021.   GlobeNewswire Inc
Mar 29, 2021
04:37PM EDT  Venus Concept: Q4 Earnings Insights   Benzinga
04:15PM EDT  Venus Concept Q4 EPS $(0.34) Misses $(0.19) Estimate, Sales $25.83M Beat $25.42M Estimate   Benzinga
04:14PM EDT  Venus Concept Reaffirms FY 2021 Revenue Guidance   Benzinga
04:05PM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and twelve months ended December 31, 2020.   GlobeNewswire Inc
04:16AM EDT  Earnings Scheduled For March 29, 2021   Benzinga
Mar 25, 2021
09:13AM EDT  Venus Concept shares were trading higher after the company announced Venus Williams has signed on as celebrity brand ambassador/endorser for Venus Bliss.   Benzinga
07:33AM EDT  Venus Concept Announces Global Brand Ambassador Partnership with Tennis Champion and Entrepreneur Venus Williams   Benzinga
07:30AM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that Venus Williams, four-time Olympic Gold Medalist, seven-time Grand Slam Champion and entrepreneur, has signed on as celebrity brand ambassador/endorser for Venus Bliss.   GlobeNewswire Inc
Mar 22, 2021
04:36PM EDT  Venus Concept Inc Announces On March 4, It's Chinese Unit Received Notice From Market Supervision And Administration Bureau Of Xuhui District, Shanghai   Benzinga
Mar 11, 2021
04:05PM EST  Venus Concept Inc.(Venus Concept or the Company)(NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the following upcoming investor conferences in March:   GlobeNewswire Inc
Mar 4, 2021
04:05PM EST  Venus Concept Inc. to Present at the H.C. Wainwright Annual Global   GlobeNewswire Inc
Feb 9, 2021
07:30AM EST  Venus Concept Inc.(Venus Concept or the Company)(NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference.   GlobeNewswire Inc
Feb 8, 2021
04:05PM EST  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that fourth quarter and fiscal year 2020 financial results will be released after the market closes on Monday, March 29, 2021.   GlobeNewswire Inc
Jan 29, 2021
04:16PM EST  Venus Concept S-3 Filing Shows Registration For ~8.2M Share Common Stock Offering   Benzinga
Jan 14, 2021
07:12AM EST  Venus Concept Expects FY21 Total Revenue Of $98.0 Mln-$103.0 Mln   RTTNews
06:35AM EST  Venus Concept Expects Q4 Preliminary Total GAAP Revenue Of $25.3 Mln-$26.3 Mln   RTTNews
06:32AM EST  Venus Concept Sees Q4 Sales $25.3M-$26.3M Vs. $25.12M Est., FY20 Sales $77.5M-$78.5M Vs. $77.31M Est., FY21 Sales $98M-$103M Vs. $100.56M Est.   Benzinga
06:30AM EST  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2020 and introduced revenue guidance expectations for the twelve months ended December 31, 2021.   GlobeNewswire Inc
Jan 5, 2021
04:05PM EST  Venus Concept Inc.(Venus Concept or the Company)(NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the following upcoming investor conferences in January:   GlobeNewswire Inc
Dec 22, 2020
02:32PM EST  Mid-Afternoon Market Update: Dow Falls 120 Points; Soligenix Shares Plummet   Benzinga
01:00PM EST  Mid-Day Market Update: Crude Oil Down 1.8%; Ocugen Shares Spike Higher   Benzinga
08:56AM EST  Venus Concept Prices 11.25M Share Common Stock Offering At $2/Share   Benzinga
08:55AM EST  Venus Concept Inc. Announces Pricing of $22.5 Million Public Offering   GlobeNewswire Inc
Dec 21, 2020
04:06PM EST  Venus Concept Inc. Announces Proposed Public Offering; Terms Not Disclosed   Benzinga
04:05PM EST  Venus Concept Inc. Announces Proposed Public Offering   GlobeNewswire Inc
Dec 18, 2020
04:22PM EST  Venus Concept 13D Filing Shows Madryn Asset Management Has A 20.3% Stake In Co.   Benzinga
Dec 10, 2020
06:32AM EST  Venus Concept Announces Debt Refinancing And Amendment Of Its Existing Revolving Credit Facility With City National Bank Of Florida   Benzinga
06:30AM EST  Venus Concept Announces Debt Refinancing   GlobeNewswire Inc
Dec 9, 2020
06:32AM EST  Stifel Initiates Coverage On Venus Concept with Hold Rating, Announces Price Target of $2.5   Benzinga
Dec 1, 2020
04:05PM EST  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company will host a virtual Aesthetic & Hair Restoration Technology event on Thursday, December 10, 2020. The live webcast of the event will begin at 10:00 a.m. ET and conclude at approximately 12:00 p.m. ET.   GlobeNewswire Inc
Nov 17, 2020
07:19AM EST  Oppenheimer Upgrades Venus Concept to Outperform, Announces $4 Price Target   Benzinga
Nov 16, 2020
10:21AM EST  Venus Concept shares were trading higher after the company reported better-than-expected Q3 EPS and sales results.   Benzinga
07:52AM EST  Recap: Venus Concept Q3 Earnings   Benzinga
07:47AM EST  Venus Concept Q3 GAAP Net Loss $7.3 Mln Vs Loss $9.0 Mln Last Year   RTTNews
07:34AM EST  Venus Concept Q3 EPS $(0.18) Beats $(0.22) Estimate, Sales $26.20M Beat $21.07M Estimate   Benzinga
07:30AM EST  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2020.   GlobeNewswire Inc
04:26AM EST  Earnings Scheduled For November 16, 2020   Benzinga
Nov 3, 2020
04:05PM EST  Venus Concept Inc.(Venus Concept or the Company)(NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management will participate in the Stifel 2020 Virtual Healthcare Conference. Management will present on Monday, November 16th at 4:00 p.m. Eastern Time.   GlobeNewswire Inc
Oct 20, 2020
07:52AM EDT  Ladenburg Thalmann Initiates Coverage On Venus Concept with Buy Rating   Benzinga
Oct 15, 2020
04:05PM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal year 2020 financial results will be released before the market opens on Monday, November 16, 2020.   GlobeNewswire Inc
Aug 13, 2020
04:18PM EDT  Venus Concept Q2 EPS $(0.39) Misses $(0.37) Estimate, Sales $17.00M Beat $15.59M Estimate   Benzinga
04:06PM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2020.   GlobeNewswire Inc
04:03AM EDT  Earnings Scheduled For August 13, 2020   Benzinga
Jul 16, 2020
07:37AM EDT  Venus Concept Expects Preliminary Q2 Total GAAP Revenue To Be $16.4 Mln-$16.9 Mln   RTTNews
07:33AM EDT  Venus Concept Sees Prelim. Q2 GAAP Revenue $16.4M-$16.9M vs $14.67M Est.   Benzinga
07:30AM EDT  Venus Concept Inc. (Venus Concept or the Company) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary revenue results for the three months ended June 30, 2020.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC